A Study Evaluating B Cell Levels In Infants Potentially Exposed To Ocrelizumab During Pregnancy

Clinical trial NCT04998812 · COMPLETED

Trial details

NCT number: NCT04998812
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Multiple Sclerosis Clinically Isolated Syndrome

Start date: 2022-04-13
Primary completion: 2024-04-08
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.